medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2010, Number 3

<< Back Next >>

Arch Inv Mat Inf 2010; 2 (3)

Epidemiología y tratamiento de conjuntivitis alérgica en un Hospital Pediátrico

Morales MDA, Zepeda OB, Mendieta AGG

Language: Spanish
References: 14
Page: 108-112
PDF size: 129.04 Kb.


ABSTRACT

Introduction: Allergic conjunctivitis is very common in the childhood and must be adequately treated by pediatricians, pediatric allergists and ophthalmologist. This disease includes a spectrum of clinical alterations involving different levels of activity of Th2 cells in the conjunctival immune response. The treatment of this condition focuses on the resolution of symptoms, but now there are new therapeutic interventions created from better understanding of this pathophysiology. Objective: To determine the frequency of allergic conjunctivitis in the period from 2005 to 2009 at Children´s Hospital of IMIEM. Material and methods: Study observational, retrospective and descriptive. We reviewed all records with the diagnosis of allergic conjunctivitis IMIEM Hospital of Children in the period from 1 January 2005 to 31 December 2009. Results: The frequency of 2005 to 2009 of allergic conjunctivitis in the Hospital for Children IMIEM was 3.15/1000. The peak frequency for allergic conjunctivitis was 7 years, followed by 6 and 8 years, male gender was more common. The year 2009 showed the highest number of cases. The type of allergic conjunctivitis was more frequent classification perennial conjunctivitis. Conclusions: The frequency of allergic conjunctivitis in the Hospital for Children of IMIEM, aggress with that reported in the literature on gender and age group.


REFERENCES

  1. Adkinson FN, Yunginger JW. Allergic and immunologic diseases of the eye. In: Adkinson FN, Yunginger JW, Busse WW, Bochner BS, editors. Middleton’s Allergy Principles and Practice. 6th ed. New York. Mosby, 2003: 1599-1617.

  2. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992; 89: 1-13.

  3. Vichyanon P. Childhood allergic conjunctivitis and vernal keratoconjunctivitis. Allergy Clin Immunol Int: J World Allergy Org 2004; 16: 132-6.

  4. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000; 106: 1019-32.

  5. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115: 118-22.

  6. Bielory L. Allergic and immunologic disorders of the eye. Part I: immunology of the eye. J Allergy Clin Immunol 200; 106: 895-15.

  7. McGill JI, Holgate ST, Church MK, Anderson DF, Bacon A. Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82: 1203-14.

  8. Stern ME, Siemasko KF, Niederkon JY. The Th1/Th2 paradigm in ocular allergy. Curr Opin Allergy Clin Immunol 2005; 5: 446-50.

  9. Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 2004; 4: 441-5.

  10. Chambless SL, Trocme S. Developments in ocular allergy. Curr Opin Allergy Clin Immunol 2004; 4: 431-4.

  11. Abelson MB. Update on allergy medications: here’s help in choosing the single best therapeutic option for ocular allergy. Rev Ophthalmol 2001. En http://www.revophth.com/2001/ March/March01medications.htm

  12. Leonardo B, Mitchell H. Allergic conjunctivitis. Immunol Allergy Clin Am 2008; 28: 43-81.

  13. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye 2004; 18: 345-51.

  14. Avunduk AM, Avunduk MC, Dayanir V, Tekelioglu Y, Dayioglu YS. A flow cytometric study about the immunopathology of vernal keratoconjunctivitis. J Allergy Clin Immunol 1998; 101: 821-4.




2020     |     www.medigraphic.com